Michael Keller

Title: Michael Keller - Innovator in Cyclosporin Derivatives

Introduction

Michael Keller is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclosporin derivatives. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Keller holds a patent for "Cyclosporin derivatives and method for the production of said derivatives." This invention relates to cyclosporin derivatives, whereby the peptide chain comprises at least one pseudo-proline type non-natural amino acid radical. The patent also details a method for the production of these derivatives, highlighting Keller's innovative approach to enhancing the efficacy of cyclosporin.

Career Highlights

Michael Keller is associated with Debiopharm S.A., a company known for its commitment to developing innovative therapies. His work at Debiopharm has allowed him to focus on groundbreaking research and development in the pharmaceutical industry. Keller's contributions have been instrumental in advancing the understanding and application of cyclosporin derivatives.

Collaborations

Keller has collaborated with esteemed colleagues such as Manfred Mutter and Roland M Wenger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective work.

Conclusion

Michael Keller's contributions to the field of pharmaceuticals, particularly through his patent on cyclosporin derivatives, demonstrate his commitment to innovation and medical advancement. His work continues to influence the industry and pave the way for future developments.